Skip to main content
Click here to get access to our Free Course on Momentum Investing Strategy

NSE · INDOBORAX

INDOBORAXC

CommoditiesChemicals & Petrochemicals₹1198 cr market cap
₹370.55 ▼ -0.67% today As of 19 Nov 2026
52-week low ₹237.5352-week high ₹516.05

-27.7% from the 52-week high · +57.1% above the low

Indo Borax & Chemicals Ltd. engages in the manufacturing and sale of chemicals. The company is headquartered in Mumbai, Maharashtra and currently employs 98 full-time employees. Its products include borax, boric acid, and lithium hydroxide monohydrate. The Company’s borax products include borax decahydrate crystal and borax decahydrate granular; boric acid includes boric acid Indian Pharmacopoeia (IP) grade, boric acid tech grade granular and boric acid tech grade powder. Its product, borax decahydrate crystal, is used as fluxes and metallurgical operations (welding and brazing steel industry (paste fluxes, soldering fluxes). Its boric acid IP uses include eyewash, ointments, foot powder, shampoo, skin cream, mouthwash, and veterinary formulations. Its product, borax decahydrate granular, is used in fused products, such as glass, glass fiber ceramics, frits, glazed and porcelain enamels. Borax decahydrate crystal is also used in fertilizers as micronutrients. Its lithium hydroxide monohydrate is used in manufacturing lubricating greases.

The short version. INDOBORAXC reported revenue of ₹59 crore for Sep 2026, up 1.7% from a year earlier. Net profit was ₹5 crore (down 68.8% year on year). Return on equity was 13.0% in Mar 2026. Promoter holding was 38.41% in Sep 2026, down 12.38 points over 8 quarters.

1 · The price

How has the stock traded?

INDOBORAXC trades 27.7% below its 52-week high and 57.1% above its 52-week low.

Change over period: —

1M-18.6%
3M-14.0%
6M+35.7%
1Y+47.7%

2 · The business

Is it growing?

Sales, year on year+1.7%

Sep 2026 revenue of ₹59 cr.

Profit, year on year-68.8%

Sep 2026 net profit of ₹5 cr.

Net margin8.1%

20.0 pts lower than a year earlier.

3-year growth-0.3% profit

Revenue compounded at -0.2% over the same 3 years.

Reported results · ₹ crore

Revenue and profit

Show the numbers

Quarterly

Sep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue5970634158545038
Net profit51615101610109
Net margin %8.123.123.124.128.119.020.424.2
EPS (₹)1.485.074.533.075.073.183.192.83

Annual

FY2026FY2025FY2024FY2023FY2022FY2021FY2020FY2019
Revenue215175191225176144115128
Net profit5043395136341718
Net margin %23.324.320.422.520.723.814.713.7
EPS (₹)15.6713.2512.1515.811.3310.685.285.46

3 · The quality

How well does it turn capital into profit?

Return on equity was 13.0% in Mar 2026; debt to equity is 0.00.

Profitability · 4 years

Returns and margins

Mar 2026Mar 2025Mar 2024Mar 2023
Return on equity %13.012.713.319.9
Return on capital %17.117.417.626.8
EBITDA margin %30.232.226.930.4
Net margin %21.822.319.221.8

Compound growth

Revenue vs profit

3 years5 years
Revenue CAGR-0.2%9.3%
Profit CAGR-0.3%8.0%
Debt to equity0.00
Interest cover1007.3x
Current ratio20.85
P/E ratio26.8

4 · The owners

Who holds it, and are they adding?

Promoter holding38.41%

Down 12.38 pts over 8 quarters.

Foreign institutions0.1%

Up 0.09 pts over 8 quarters.

Domestic institutions0.04%

Up 0.04 pts over 8 quarters.

Mutual fund schemes0

+0 versus the previous month.

Shareholding pattern (%)

Quarter by quarter

Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026Change
Promoter50.7950.7950.7950.7950.7930.838.4138.41-12.38
FII0.010.020.020.530.230.450.130.1+0.09
DII00.010.020.020.022.190.040.04+0.04
Public49.249.1749.1648.6648.9666.5661.4261.44+12.24

5 · The model view

What does our factor model say?

Factor scores, model flags and screen results for INDOBORAXC are part of the Wright portfolio review.

Run your free portfolio review

Watchouts

What to review

Model flags are shown inside the portfolio review, alongside your other holdings.

Model ratingLocked
Factor betaLocked
VolatilityLocked

Quick answers

Common questions about INDOBORAXC

What is the INDOBORAXC share price?

INDOBORAXC (INDOBORAX) last closed at ₹370.55, down 0.67% on the day. Its 52-week range is ₹237.53 to ₹516.05.

What is the market cap of INDOBORAXC?

INDOBORAXC has a market capitalisation of about ₹1,198 crore. Its price-to-earnings ratio is 26.8.

How are INDOBORAXC's latest results?

INDOBORAXC reported revenue of ₹59 crore for Sep 2026, up 1.7% from a year earlier. Net profit was ₹5 crore (down 68.8% year on year). Return on equity was 13.0% in Mar 2026. Promoter holding was 38.41% in Sep 2026, down 12.38 points over 8 quarters.

Who owns INDOBORAXC?

As of Sep 2026, shareholding was: Promoter 38.41%, FII 0.1%, DII 0.04%, Public 61.44%.

How many mutual funds hold INDOBORAXC?

0 mutual fund schemes held INDOBORAXC in October 2026. That compares with 0 the month before.

Corporate actions

Recent dividends, bonuses and splits

  • 18 Sep 2025 · Final Dividend - Rs. 1
  • 20 Aug 2024 · Final Dividend - Rs. 1
  • 11 Aug 2023 · Dividend - Rs. 1
  • 18 Aug 2022 · Final Dividend - Rs. 1
  • 27 Sep 2021 · Stock Split From Rs.10/- to Rs.1/-
  • 24 Aug 2021 · Final Dividend - Rs. 10

Financials are as reported by the company (consolidated), in ₹ crore. Source: FinEdge exchange filings feed. Figures can differ from other sites because of one-off items and restatements. Callouts above are arithmetic on reported data, not recommendations.

Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.